| Announce Date | 11/06/2025 |
| EPS Normalized Actual | $1.22 (Beat by $0.2) |
| EPS GAAP Actual | $1.22 (Beat by $0.2) |
| Revenue Actual | $1.694B |
| Revenue Surprise | Beat by $1694M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $1.4 |
| EPS GAAP Estimate | $1.4 |
| Revenue Estimate | $1.348B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2028 | 7.67 | 3.7 | 7.67 | 7.67 | 1 |
| Dec 2027 | 7.88 | 3.6 | 7.52113 | 8.23887 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.86 | -0.43 | 1.694B | 19.66% | 285M |
| FQ2 2025 (Jun 2025) | 0.26 | -1.025 | 1.384B | 100% | -29M |
| FQ1 2025 (Mar 2025) | -0.2 | -1.435 | 0.908B | 100% | -468M |
| FQ4 2024 (Dec 2024) | 2.58 | 1.38 | 1.47B | 100% | 199M |
| FQ3 2024 (Sep 2024) | -0.0806 | -0.0806 | 1.361B | 100% | 1361M |
| FQ1 2016 (Mar 2016) | -0.01 | -0.01 | 0B | NAN% | 0M |
| FQ2 2016 (Jun 2016) | -0.0335 | -0.0335 | 2.4685E-5B | 100% | 0.02M |
| FQ3 2016 (Sep 2016) | 0.0016 | 0.0016 | 0.000427153B | 100% | 0.43M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
1.4
Consensus Revenue Estimates
1.348B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 1.75 | -- | 1.75 | 1.75 | 1 |
| FQ3 2027 (Sep 2027) | 1.68 | -- | 1.68 | 1.68 | 1 |
| FQ2 2027 (Jun 2027) | 1.6 | -- | 1.6 | 1.6 | 1 |
| FQ1 2027 (Mar 2027) | 1.52 | -- | 1.52 | 1.52 | 1 |
| FQ4 2026 (Dec 2026) | 1.65 | -- | 1.59996 | 1.70004 | 1 |
| FQ3 2026 (Sep 2026) | 1.57 | 45.22 | 1.52239 | 1.61761 | 1 |
| FQ2 2026 (Jun 2026) | 1.48 | 82.43 | 1.43512 | 1.52488 | 1 |
| FQ1 2026 (Mar 2026) | 1.4 | 114.29 | 1.35754 | 1.44246 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 1.75B | -- | 1.75B | 1.75B | 1 |
| FQ3 2027 (Sep 2027) | 1.71B | -- | 1.71B | 1.71B | 1 |
| FQ2 2027 (Jun 2027) | 1.67B | -- | 1.67B | 1.67B | 1 |
| FQ1 2027 (Mar 2027) | 1.62B | -- | 1.62B | 1.62B | 1 |
| FQ4 2026 (Dec 2026) | 1.47B | -- | 1.43B | 1.5B | 1 |
| FQ3 2026 (Sep 2026) | 1.43B | -18.71 | 1.39B | 1.46B | 1 |
| FQ2 2026 (Jun 2026) | 1.39B | 0.22 | 1.35B | 1.42B | 1 |
| FQ1 2026 (Mar 2026) | 1.35B | 32.64 | 1.32B | 1.38B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
2
EPS # of Misses
6
EPS # of in-lines
0
Revenue # of Beats
5
Revenue # of Misses
2
Revenue # of in-lines
1
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 1.29 | 0.86 | -0.43 | -50% |
| FQ2 2025 (Jun 2025) | 1.285 | 0.26 | -1.025 | -394.23% |
| FQ1 2025 (Mar 2025) | 1.235 | -0.2 | -1.435 | 717.5% |
| FQ4 2024 (Dec 2024) | 1.2 | 2.58 | 1.38 | 53.49% |
| FQ3 2024 (Sep 2024) | -0.0806 | -0.0806 | 100% | |
| FQ1 2016 (Mar 2016) | -0.01 | -0.01 | 100% | |
| FQ2 2016 (Jun 2016) | -0.0335 | -0.0335 | 100% | |
| FQ3 2016 (Sep 2016) | 0.0016 | 0.0016 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $1.41B | $1.69B | $285M | 16.82% |
| FQ2 2025 (Jun 2025) | $1.41B | $1.38B | $-29M | -2.1% |
| FQ1 2025 (Mar 2025) | $1.38B | $0.91B | $-468M | -51.54% |
| FQ4 2024 (Dec 2024) | $1.27B | $1.47B | $199M | 13.54% |
| FQ3 2024 (Sep 2024) | $0B | $1.36B | $1361M | 100% |
| FQ1 2016 (Mar 2016) | $0B | $0B | $0M | NAN% |
| FQ2 2016 (Jun 2016) | $0B | $0B | $0.02M | 100% |
| FQ3 2016 (Sep 2016) | $0B | $0B | $0.43M | 100% |